Study title: A Randomized, Multi-Cohort Phase II Trial of Temozolomide and Atezolizumab
as Second Line Treatment for Small Cell Lung Cancer

• Open to Accrual at:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Simon Bren Comprehensive Cancer Center 
  • Holden Comprehensive Cancer Center, University of Iowa
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute 
  • University of Wisconsin Carbone Cancer Center
• Learn more
  • clinicaltrials.gov: NCT04919382
• Publications and Presentations: 
  • Poster Presentation: 2024 American Society of Hematology Annual Meeting

Study Contact: studies@hoosiercancer.org; 317-921-2050